Idera Pharmaceuticals’ $20 Million Private Placement

Morgan Lewis represented Idera Pharmaceuticals Inc. in the transaction. Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) entered into an agreement with a fund affiliated with institutional investors providing…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now